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Reducing racial health disparities is often stated as a population
health goal, but specific targets for such improvement are seldom
set. It is often assumed that improving overall health outcomes
will be linked to disparity reduction, but this is not necessarily the
case.
Methods
We compared the annual change from 1999 through 2013 in com-
bined-race (black and white) mortality with the annual change in
absolute and relative racial mortality disparities for US states.
Results
Median  annual  improvement  in  combined-race  mortality  was
1.08% per year. Annual overall mortality rate reductions ranged
from 0.24% per year in Oklahoma to 1.83% per year in Maryland.
For disparities, the median for the black–white absolute gap was
3.60% per year, and the median for the relative black-to-white ra-
tio  was  1.19% per  year.  There  was  no  significant  correlation
between the combined-race measure and either the absolute (0.03)
or relative disparity measure reductions (−0.17).
Conclusion
For mortality in US states over a recent period, improvement in
the population mean and disparity reduction do not usually occur
together. The disparity reduction rates observed may provide real-
istic guidance for public and private policy makers in setting goals
for reducing population health disparity and creating investment
priorities. As a starting point for discussion, the observed national
median annual percentage improvement of 1.1 per year combined,
3.6% per year absolute gap reduction, and 1.2% per year relative
gap reduction would be modest and reasonable goals.
Introduction
National and state health outcome goals are often framed in terms
of improving the population mean and reducing or eliminating dis-
parities within the population. For example, in Healthy People
2020, the 2 overarching goals are 1) attain high-quality, longer
lives free of preventable disease, disability, injury, and premature
death, and 2) achieve health equity, eliminate disparities, and im-
prove the health of all groups (1). However as Keppel et al poin-
ted out with regard to Healthy People 2010, the first goal does not
necessarily achieve health equity, eliminate disparities, and im-
prove the health of all groups (2). Different strategies are often
needed for these 2 goals, and innovations often have higher effect,
at  least  initially,  on well-educated or  advantaged populations,
which can at least temporarily increase disparities (2–4).
Trends in state health outcomes show large variations over time
(5–8). Satcher et al showed that the black–white gap in mortality
rates changed little between 1960 and 2000 (9). Another recent
study found that  large racial  disparities  in some states are ex-
plained by higher-than-average life expectancy among whites or
lower-than-average life expectancy among blacks (10). Webb et al
constructed a health disparity index by race, which compared state
performance but did not contrast disparity reduction with mean
improvement (11).
To our knowledge no jurisdiction in the United States has emphas-
ized the potential trade-off between these 2 outcomes or given
policy attention to how such trade-offs should be addressed. The
objective of this study was to describe what US states recently ex-
perienced in overall mean improvement in mortality compared
with the improvement in the black–white mortality gap. We tested
the hypothesis that states that experience the greatest improve-
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ments in combined-race mortality also experience the greatest im-
provements in reducing racial disparities. We hope that such evid-
ence will guide policy and investment planning so that the United
States and the 50 individual states can set reasonable annual im-
provement targets to achieve in the coming decades.
Methods
Data on age-adjusted mortality come from the publicly available
CDC Wonder’s Compressed Mortality Database (12). We extrac-
ted mortality data on people younger than 75 years for all 50 US
states and Washington, DC, for all sexes, for blacks, and for white
non-Hispanics for all years from 1999 through 2013. Mortality
was calculated per 100,000 people and age-adjusted by using the
2000 US standard population.
We calculated the annual percentage change for the combined
mortality of both races as well as by 2 mortality disparity meas-
ures for each state: racial gap as an absolute disparity measure and
the black-to-white ratio as a relative disparity measure. Absolute
disparity  refers  to  the  simple  difference  in  a  health  outcome,
whereas relative disparity  refers  to  the health  outcome of  one
group as a ratio of the other’s health outcome. To generate annual
percentage changes, we used Stata/SE 14.0 (StataCorp LP) to pre-
dict values from a linear regression of each measure on years for
each state, providing a smooth linear trend (13).
The absolute mortality gap by race was calculated by subtracting
the white age-adjusted mortality from the black age-adjusted mor-
tality for each year and each state. States that reported 50 or fewer
deaths in 2000 in either racial category were excluded from our
analysis because too few events can cause large variation in year-
to-year  mortality;  for  blacks,  the  states  excluded  were  Idaho,
Maine, Montana, New Hampshire, North Dakota, South Dakota,
Vermont, and Wyoming. Also excluded from our analysis were 4
states with a statistically insignificant relationship between the
age-adjusted mortality racial gap and year according to a linear re-
gression model of age-adjusted mortality racial gap and year: the
excluded states were Alaska, Hawaii, West Virginia, and Wiscon-
sin. If a basic linear regression reveals statistically insignificant
results, we cannot conclude that these states’ disparity reductions
were statistically different from zero.
Recently  published  research  results  note  that  decisions  about
measuring disparities using absolute or relative methods, such as
group rankings and direction and magnitude of changes over time,
has an effect on results (14–16). Therefore, we follow the recom-
mendation to examine and report both absolute and relative dispar-
ity results.  The relative disparity measure we examined was a
black-to-white ratio of age-adjusted mortality for each state. Five
additional states were found not to have significant annual per-
centage changes in relative mortality disparity and therefore were
excluded from the relative-disparity portion of our analysis: Color-
ado, Iowa, Nebraska, New Mexico, and Utah.
Results
The Table describes 1) the relationship across the states examined
between annual state percentage improvement in mortality and 2)
the change in the absolute racial gap and relative racial disparity
from 1999 through 2013. The mean combined-race mortality rate
of  annual  improvement  was  1.11%,  (standard  deviation  [SD]
0.42%). The range was from 1.83% in Maryland to 0.24% in Ok-
lahoma. For annual percentage change in the racial gap, the mean
was a reduction of 3.64% per year (SD, 0.97%). The range was
from 6.6% in Rhode Island to 2.13% in Iowa. For annual percent-
age change in the black-to-white ratio, the mean was an annual re-
duction of 1.2% (SD, 0.4%). State mortality varied from 2.47% in
Rhode Island to 0.43% in California. Figure 1 displays findings
for the absolute disparity measure for all states examined.
Figure 1. Racial gap between blacks and whites versus annual percentage
change in combined-race mortality: variation in 38 states’ annual percentage
improvement  in  combined-race  mortality  and  in  absolute  racial  gaps,
1999–2013.
 
The extent of improvement in combined mortality was not correl-
ated with the reduction in the racial mortality gap (correlation
coefficient = 0.03). Some states (eg, Massachusetts, Georgia) im-
proved substantially on both combined-race mortality and abso-
lute racial gap outcomes while other states’ (eg, Oklahoma, Iowa)
improvement on both was not as great. Similarly, states (eg, Cali-
fornia, Illinois) did well on combined-race mortality improvement
but not as well on absolute racial gap improvement. Conversely,
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some states (eg, Kentucky, Tennessee) failed to have great im-
provements in combined-race mortality but saw a large reduction
in the absolute racial gap from 1999–2013. In every state there
was improvement in both black and white mortality, but improve-
ment in black mortality was always greater (data not shown).
Figure 2 displays a similar relationship between relative disparity
and annual percentage changes in combined-race mortality across
states. Again, the extent of state improvement in combined mortal-
ity is not correlated with the reduction in the relative black-to-
white ratio disparity measure (correlation coefficient = −0.17).
Massachusetts and Maryland improved substantially on both com-
bined-race mortality and relative racial gap outcomes while other
states’ (eg, Oklahoma, Kansas) improvement on both was not as
great. California and Illinois improved greatly on the combined-
race mortality rate but not as well on the relative black-to-white
ratio; the opposite was true for Kentucky and Tennessee.
Figure  2.  Relative  racial  disparity  versus  annual  percentage  change  in
combined-race  mortality:  variation  in  33  states’  annual  percentage




The lack of a strong relationship between the combined improve-
ment in mortality and improvement in the disparity gaps answers
the question posed in the title and in our hypothesis; most states
have not achieved these 2 outcomes simultaneously. Some states,
such as Massachusetts, did well on both mean mortality improve-
ment and disparity reduction, while others,  such as Oklahoma,
have had difficulty with both. However, states often perform well
with one dimension but struggle with the other.
We believe our data provide some guidance about what is pos-
sible for any state to achieve. At least one state, Maryland, experi-
enced an annual improvement in combined mortality by 1.83%
from 1999 through 2013; at least one state, Rhode Island, experi-
enced an annual improvement of 6.6% per year in the black–white
mortality absolute gap; at least one state, Rhode Island, had an an-
nual improvement of 2.47% per year in the relative black-to-white
mortality ratio. These are not theoretical targets; they are results
that were achieved by at least one state during the past decade.
Massachusetts  performed the best  in simultaneous overall  im-
provement (1.74%), absolute disparity reduction (4.73%), and rel-
ative disparity reduction (1.3%). More work could also model and
project realistic overall and disparity reduction targets that the
United States and the individual US states could each achieve by
using the highest performing states as guides. As a starting point
for discussion, the observed national median annual percentage of
1.1% combined improvement, 3.6% absolute gap reduction, and
1.2% relative gap reduction could be future state continuous im-
provement  benchmarks.  Some states  might  want  to  use  these
baselines to develop targets, while others might want to use as
baselines what peer states accomplished.
Our results reinforce the importance of reporting disparity results
in both absolute and relative terms.  Although neither measure
showed an overall correlation with combined mortality improve-
ment, there were differences across the states depending on the
disparity  measure  used.  Although each  disparity  measure  has
slightly different results, the annual percentage change for abso-
lute and relative disparity are strongly linked (correlation coeffi-
cient = 0.91). Although in this study both measures showed im-
provement, there are examples where one measure improves but
the other does not (17). Since neither is intrinsically preferable
from a policy perspective, policy makers should continue to meas-
ure and target reductions in both.
Several limitations should be considered when interpreting our
results. This analysis is limited to all-cause mortality; additional
research is needed to look into age-specific mortality as well as
non-mortality outcomes such as morbidity and health-related qual-
ity of life measures (18). In addition, specific-age groups should
be examined to see whether there are life stage differences in these
findings. We limited our analysis to state changes, so we do not
know the extent of variation across counties in improvements or
declines in trends. Nor did we examine other disparity domains
such as socioeconomic status, which should be investigated since
health-related socioeconomic disparities are large and are seen in
every state (19). It would also be useful to examine other periods
to determine whether the range in improvement we found was
achieved in other periods, since what occurred in our study period
might be an imperfect guide to future possibilities; the mortality
experience of the previous cohorts that produced these results may
be different in either direction for more recent cohorts.
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Of course, these results do not indicate how any state achieved the
results that we show here. We use the term “experienced” expli-
citly rather than “produced,” since it is unclear and probably un-
likely that any states produced such results intentionally in re-
sponse to explicit mean improvement-disparity reduction targets,
although Maryland set mean and disparity targets for a variety of
health outcomes and determinants (20). Nor do we know the most
cost-effective  way of  achieving  the  improvement  some states
achieved, either in any one of the measures or both together. Al-
though we are beginning to collect  evidence on effective pro-
grams and policies, such evidence often shows relationships for
mean improvement rather than disparity reduction and overall ef-
fectiveness instead of cost effectiveness (21). Examining the states
that performed well and states that performed poorly on both di-
mensions may reveal clues about the most effective policy pack-
ages to use for large improvement.
If a public or a private policy maker were interested in trying to
determine what would produce optimal results, some standard of
what “optimal” means would need to be defined. For this purpose,
we believe it would be useful to have some summary metric of
mean and disparity gap improvement such as the achievement in-
dex suggested by Wagstaff (22). As Wagstaff indicated, such a
metric would have to reflect a value choice of the relative import-
ance of mean improvement in mortality versus disparity reduction.
Such a metric could be more complicated than the one he pro-
posed, since several disparity domains also need to be considered.
Since different states or communities would probably value each
component (or each disparity domain) differently, a useful tool
would be one that allows different weights to be used for each
component so that achievement progress could be assessed com-
ponent by component, perhaps beginning with a default standard
that weighted components equally.
Despite these challenges, we believe that our results are useful
now in beginning to set benchmarks for what is possible and to
identify programs and policies that are most closely related to im-
proved performance. We encourage public and private entities to
1) review what many states achieved in both general improve-
ment and disparity reduction and 2) set policy and investment pri-
orities in accordance with their own values and perspectives (23).
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Table
Table. State Annual Percentage Variation in Improvement in Combined-Race (Black and White) Mortalitya, Absolute Racial Gap, and Relative Racial Gap,
1999–2013
Category Mean Median High Low Standard Deviation
Combined-race mortality (38 states) −1.11 −1.08 −1.83 −0.24 0.42
Absolute racial gap (38 states) −3.64 −3.60 −6.6 −2.13 0.97
Combined-race mortality (33 states)b −1.14 −1.16 −1.83 −0.24 0.43
Relative racial disparity (33 states)b −1.2 −1.19 −2.47 −0.43 0.4
a Mortality was calculated per 100,000 people and age-adjusted by using the 2000 standardized US population.
b Only 33 states were relevant for the method used to measure relative disparity.
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